Research programme: microencapsulated cell therapy - diabetes - PharmaCyte Biotech

Drug Profile

Research programme: microencapsulated cell therapy - diabetes - PharmaCyte Biotech

Alternative Names: Bio-artificial pancreas - PharmaCyte Biotech; Encapsulated cell therapy - diabetes - PharmaCyte Biotech

Latest Information Update: 28 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nuvilex
  • Developer PharmaCyte Biotech; University of Veterinary Medicine, Vienna
  • Class Cell therapies
  • Mechanism of Action Pancreatic beta cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Diabetes mellitus

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for preclinical development in Diabetes-mellitus in Singapore (Parenteral, Implant)
  • 12 May 2016 PharmaCyte Biotech receives patent allowance for the use of Melligen cells for the treatment of Diabetes in USA
  • 15 Jul 2015 PharmaCyte Biotech has patent protection for Melligen cells in Europe, France, Switzerland, Great Britain, Ireland, Germany, Spain, Denmark, Italy and the Netherlands
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top